Literature DB >> 6453884

Reactions to niacinamide.

H S Zachkeim, D B Vasily, M L Westphal, C W Hastings.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6453884     DOI： 10.1016/s0190-9622(81)80211-3

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  7 in total

1.  Reversal of acquired cisplatin resistance by nicotinamide in vitro and in vivo.

Authors:  G Chen; W J Zeller
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

2.  Pharmacokinetics and biochemistry studies on nicotinamide in the mouse.

Authors:  M R Stratford; M F Dennis
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

3.  Pre-emptive Short-term Nicotinamide Mononucleotide Treatment in a Mouse Model of Diabetic Nephropathy.

Authors:  Itaru Yasuda; Kazuhiro Hasegawa; Yusuke Sakamaki; Hirokazu Muraoka; Takahisa Kawaguchi; Ei Kusahana; Takashi Ono; Takeshi Kanda; Hirobumi Tokuyama; Shu Wakino; Hiroshi Itoh
Journal:  J Am Soc Nephrol       Date:  2021-04-01       Impact factor: 14.978

4.  Pharmacokinetics of varying doses of nicotinamide and tumour radiosensitisation with carbogen and nicotinamide: clinical considerations.

Authors:  A Rojas; R J Hodgkiss; M R Stratford; M F Dennis; H Johns
Journal:  Br J Cancer       Date:  1993-12       Impact factor: 7.640

5.  Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time.

Authors:  D J Chaplin; M R Horsman; D W Siemann
Journal:  Br J Cancer       Date:  1993-08       Impact factor: 7.640

6.  DNA damage and repair in tumour and non-tumour tissues of mice induced by nicotinamide.

Authors:  A R Olsson; Y Sheng; R W Pero; D J Chaplin; M R Horsman
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

7.  Nicotinamide mononucleotide ameliorates adriamycin-induced renal damage by epigenetically suppressing the NMN/NAD consumers mediated by Twist2.

Authors:  Kazuhiro Hasegawa; Yusuke Sakamaki; Masanori Tamaki; Shu Wakino
Journal:  Sci Rep       Date:  2022-08-12       Impact factor: 4.996
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.